Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit

التفاصيل البيبلوغرافية
العنوان: Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit
المؤلفون: Pere Trias-Sabria, Nuria Romero, Yolanda Ruiz, Ana Cordoba, Guillermo Suarez-Cuartin, Salud Santos, Maria Molina-Molina, Joan Sabater, Alfredo Marin, Ester Cuevas, Cristina Subirana, Merce Gasa, Albert Ariza, Mikel Sarasate, Marta Hernandez-Argudo, Guadalupe Bermudo
المصدر: Frontiers in Medicine
Dipòsit Digital de la UB
Universidad de Barcelona
Frontiers in Medicine, Vol 8 (2021)
بيانات النشر: Frontiers Media S.A., 2021.
سنة النشر: 2021
مصطلحات موضوعية: Medicine (General), medicine.medical_specialty, high-flow nasal cannula, Lower risk, law.invention, 03 medical and health sciences, R5-920, 0302 clinical medicine, law, Internal medicine, medicine, Monitoratge de pacients, pneumonia, 030212 general & internal medicine, Original Research, Patient monitoring, business.industry, Proportional hazards model, Mortality rate, non-invasive ventilation, COVID-19, Retrospective cohort study, General Medicine, IMCU, medicine.disease, Intensive care unit, mortality, Pneumonia, 030228 respiratory system, ICU, Medicine, business, Respiratory care, Kidney disease, intermediate care unit
الوصف: Introduction: Many severe COVID-19 patients require respiratory support and monitoring. An intermediate respiratory care unit (IMCU) may be a valuable element for optimizing patient care and limited health-care resources management. We aim to assess the clinical outcomes of severe COVID-19 patients admitted to an IMCU.Methods: Observational, retrospective study including patients admitted to the IMCU due to COVID-19 pneumonia during the months of March and April 2020. Patients were stratified based on their requirement of transfer to the intensive care unit (ICU) and on survival status at the end of follow-up. A multivariable Cox proportional hazards method was used to assess risk factors associated with mortality.Results: A total of 253 patients were included. Of them, 68% were male and median age was 65 years (IQR 18 years). Ninety-two patients (36.4%) required ICU transfer. Patients transferred to the ICU had a higher mortality rate (44.6 vs. 24.2%; p < 0.001). Multivariable proportional hazards model showed that age ≥65 years (HR 4.14; 95%CI 2.31–7.42; p < 0.001); chronic respiratory conditions (HR 2.34; 95%CI 1.38–3.99; p = 0.002) and chronic kidney disease (HR 2.96; 95%CI 1.61–5.43; p < 0.001) were independently associated with mortality. High-dose systemic corticosteroids followed by progressive dose tapering showed a lower risk of death (HR 0.15; 95%CI 0.06–0.40; p < 0.001).Conclusions: IMCU may be a useful tool for the multidisciplinary management of severe COVID-19 patients requiring respiratory support and non-invasive monitoring, therefore reducing ICU burden. Older age and chronic respiratory or renal conditions are associated with worse clinical outcomes, while treatment with systemic corticosteroids may have a protective effect on mortality.
وصف الملف: application/pdf
اللغة: English
تدمد: 2296-858X
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::876c8780a7e657ca7e4f18af7831aead
http://europepmc.org/articles/PMC8280318
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....876c8780a7e657ca7e4f18af7831aead
قاعدة البيانات: OpenAIRE